腦監測市場 - 全球產業規模、佔有率、趨勢、機會及預測（按設備、最終用戶、應用、地區和競爭格局分類），2021-2031年

全球腦監測市場預計將從 2025 年的 37.8 億美元成長到 2031 年的 55.7 億美元，複合年成長率為 6.69%。

該市場涵蓋用於評估神經系統參數（包括顱內壓和腦電活動）的醫療設備和系統，以輔助診斷和治療腦部疾病。該領域的成長主要受全球人口老化和需要緊急干預的神經系統疾病病例增加的推動。世界衛生組織 (WHO) 2024 年的報告顯示，屆時全球將有超過 30 億人患有神經系統疾病，使其成為全球致殘和致病的主要原因之一。這進一步增加了在慢性病和急性病護理環境中對可靠的診斷和監測解決方案的需求。

儘管這些成長指標令人鼓舞，但由於先進監測系統高成本且報銷體系複雜，市場擴張仍面臨許多障礙。此外，全球範圍內熟練的神經科和專業醫務人員短缺，也限制了這些技術的廣泛應用。這種專業知識的匱乏嚴重阻礙了複雜生理數據的解讀，在醫療基礎設施不足以維護先進醫療設備的低度開發地區，這項挑戰尤其嚴峻。

市場促進因素

市場成長的主要促進因素是神經退化性疾病發生率的上升和老齡化人口的不斷擴大。隨著世界人口老化，阿茲海默症、帕金森氏症和失智症疾病的盛行率不斷上升，促使人們需要頻繁且準確地進行神經系統評估。這一人口趨勢迫使醫療保健機構實施先進的監測系統，以便早期發現疾病並進行持續管理，從而控制長期照護成本。根據阿茲海默症協會於2024年3月發布的《2024年阿茲海默症現況與統計》報告，約有690萬65歲以上的美國人患有老年失智症失智症。患者數量的快速成長使得使用腦電圖（EEG）和其他無創技術來監測疾病進展和治療效果變得特別必要。

此外，人工智慧和技術創新與神經診斷工具的融合正在加速腦監測解決方案的普及。機器學習和訊號處理技術的進步使設備能夠更精確地分析複雜的生理數據，從而吸引了該領域的大量投資。例如，Alto Neurosciences於2024年2月完成首次股票公開發行（IPO），籌集了約1.286億美元，用於開發其基於腦電圖（EEG）生物標記的精準精神病學平台。這標誌著該產業正向數據驅動的個人化醫療轉型。此外，對神經學基礎設施的大量投資也在推動這一趨勢。Medtronic報告稱，其神經科學產品組合在2024年創造了94億美元的收入，顯示全球資本配置對先進神經監測和干涉能力的重要性。

市場挑戰

全球腦監測市場成長面臨的主要障礙之一是專業醫護人員和熟練神經科的短缺。先進的腦監測系統會產生複雜的生理數據，需要專家分析才能提供臨床價值。因此，當醫療機構缺乏操作這些設備和解讀結果的訓練有素的人員時，就很難證明購買如此昂貴設備的合理性。這種短缺有效地限制了市場滲透，尤其是在發展中地區，這些地區現有醫療技術與操作所需人力之間的差距最為顯著。

隨著神經系統疾病的增加，人才短缺直接削弱了市場需求。世界神經病學聯合會報告稱，到2024年，低收入國家每10萬人口的神經科數量將比高所得國家少82倍。這種專業人才的巨大差距限制了醫療系統制定全面監測方案的能力。因此，儘管需要重症監護的疾病日益增多，但由於全球範圍內缺乏使用這些診斷工具所需的專業人才，市場潛力仍未充分發揮。

市場趨勢

攜帶式和穿戴式腦電監測設備的普及正在重塑市場格局，將診斷工作從神經科專科轉移到加護病房和急診室等第一線醫療機構。與傳統笨重複雜的腦電圖儀相比，這些緊湊型系統使臨床醫生能夠在床邊快速對疑似癲癇持續狀態或非驚厥性癲癇發作的患者進行分診。這種便利性的提升提高了急診護理的工作流程效率，並顯著縮短了診斷時間，從而促使醫療機構迅速採用這些設備。近期財務數據也反映了對這些靈活解決方案的需求。例如，Ceribell 在 2024 年第三季財報中報告稱，由於其人工智慧驅動的可攜式腦電圖系統在各醫院網路中的廣泛應用，其總收入成長了 48%，達到 1720 萬美元。

同時，遠端患者監護和遠距神經病學解決方案的蓬勃發展，正將神經診斷能力拓展到醫院之外，支持對睡眠障礙和癲癇等慢性疾病進行居家管理。這項轉變得益於醫療設備(SaMD) 模式和雲端平台的進步，這些平台能夠實現持續資料收集和遠距醫師診斷，有效填補了專科醫生短缺造成的空白。隨著分散式醫療保健的擴展，製造商正日益關注這些基於服務的收入來源。例如，Compumedics 公司在 2024 年 9 月宣布，軟體即服務(SaaS) 遠距監護部門貢獻了 420 萬美元的收入，顯著加速了成長，並實現了該會計年度 4,970 萬美元的創紀錄收入。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球腦監測市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 透過設備（腦電圖（EEG）、肌電圖（EMG）、腦磁圖（MEG）、顱內壓（ICP）、MRI、fMRI、CT）
  • 依最終使用者（醫院、神經科中心、診所和門診手術中心）分類
  • 依應用領域（創傷性腦損傷 (TBI)、中風、失智症、頭痛障礙、睡眠障礙、巴金森氏症、癲癇、亨丁頓舞蹈症、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美腦監測市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲腦監測市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區腦監測市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲腦監測市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 南美洲腦監測市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球腦監測市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Dragerwerk AG & Co. KGaA
• Masimo Corporation
• Cadwell Industries, Inc.
• NuroWave Systems, Inc.
• Neurosoft SA
• CGX（A Cognionics Company）
• Natus Medical, Inc.
• Nihon Kohden Corporation
• Koninklijke Philips NV
• GE HealthCare Technologies Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Brain Monitoring Market is projected to expand from USD 3.78 Billion in 2025 to USD 5.57 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.69%. This market encompasses medical devices and systems engineered to evaluate neurological parameters, including intracranial pressure and electrical activity, to aid in diagnosing and managing brain disorders. The sector's growth is largely fueled by an aging global population and the increasing prevalence of neurological issues requiring critical intervention. As reported by the World Health Organization in 2024, over 3 billion individuals globally were living with a neurological condition, positioning these disorders as the primary cause of disability and illness worldwide, thereby intensifying the need for robust diagnostic and monitoring solutions in both chronic and acute care environments.

Despite these favorable growth indicators, market expansion faces significant hurdles due to the high costs of advanced monitoring systems and complex reimbursement frameworks. Additionally, the widespread adoption of these technologies is constrained by a global scarcity of skilled neurologists and specialized healthcare staff. This lack of expertise creates a critical bottleneck in the interpretation of intricate physiological data, a challenge that is particularly acute in developing regions where healthcare infrastructure is often inadequate to sustain sophisticated medical devices.

Market Driver

The primary catalysts for market growth are the rising incidence of neurodegenerative disorders and the expansion of the geriatric demographic. As the world's population ages, the prevalence of conditions like Alzheimer's disease, Parkinson's disease, and dementia rises, creating a critical need for frequent and accurate neurological assessments. This demographic trend compels healthcare providers to implement advanced monitoring systems for early detection and ongoing management to control long-term care expenses. According to the Alzheimer's Association's "2024 Alzheimer's Disease Facts and Figures" report from March 2024, approximately 6.9 million Americans aged 65 and older suffer from Alzheimer's dementia, a surge in patient volume that necessitates increased usage of electroencephalography (EEG) and other non-invasive methods to monitor disease progression and treatment success.

Furthermore, the integration of artificial intelligence and technological innovations in neurodiagnostic tools is accelerating the adoption of brain monitoring solutions. Advances in machine learning and signal processing allow devices to analyze complex physiological data with higher precision, drawing substantial investment into the field. For example, Alto Neuroscience announced the closing of its initial public offering in February 2024, securing roughly $128.6 million to develop a precision psychiatry platform using EEG biomarkers, highlighting the industry's pivot toward data-centric, personalized care. Additionally, broader investment in neurological infrastructure supports this trend; Medtronic reported that its Neuroscience portfolio generated $9.4 billion in revenue in 2024, demonstrating significant global capital allocation toward advanced neurological monitoring and intervention capabilities.

Market Challenge

A major obstacle hindering the growth of the Global Brain Monitoring Market is the scarcity of specialized healthcare personnel and skilled neurologists. Advanced brain monitoring systems produce intricate physiological data that demands expert analysis to provide clinical value. Consequently, when healthcare facilities lack trained staff capable of operating these devices or interpreting their results, justifying the purchase of such expensive equipment becomes challenging. This shortage effectively limits market penetration, especially in developing regions where the disparity between available medical technology and the workforce necessary to operate it is most severe.

This workforce limitation directly undermines the demand generated by the growing burden of neurological diseases. According to the World Federation of Neurology, in 2024, low-income nations had up to 82 times fewer neurologists per 100,000 inhabitants compared to high-income countries. This drastic inequality in specialized human resources limits the capacity of healthcare systems to establish comprehensive monitoring programs. As a result, even though the prevalence of conditions requiring critical care is increasing, the market remains unable to achieve its full potential because the essential expertise required to utilize these diagnostic tools is missing in large sectors of the global market.

Market Trends

The market is being reshaped by the proliferation of portable and wearable brain monitoring devices, which are shifting diagnostics from specialized neurology departments to point-of-care settings such as intensive care units and emergency rooms. In contrast to traditional, bulky EEG carts that necessitate complicated setups, these compact systems empower clinicians to quickly triage patients suspected of having status epilepticus or non-convulsive seizures directly at the bedside. This increased accessibility enhances workflow efficiency and significantly shortens the time to diagnosis in acute care environments, fueling rapid adoption by healthcare facilities. The demand for these agile solutions is reflected in recent financial data; for instance, Ceribell reported a 48% rise in total revenue to $17.2 million in its third-quarter 2024 financial results, driven by the wider use of its AI-enabled, portable EEG system across hospital networks.

Simultaneously, the growth of remote patient monitoring and tele-neurology solutions is expanding neuro-diagnostic capabilities beyond hospital confines, aiding in the home management of chronic conditions like sleep disorders and epilepsy. This transition is supported by the advancement of Software-as-a-Medical-Device (SaMD) models and cloud-based platforms that facilitate continuous data collection and remote review by physicians, effectively addressing the gaps created by specialist shortages. Manufacturers are increasingly targeting these service-based revenue streams to capitalize on decentralized care. Notably, Compumedics Limited announced in September 2024 that it achieved record revenues of $49.7 million for the fiscal year, with growth significantly bolstered by its software-as-a-service (SaaS) remote monitoring division, which contributed $4.2 million in revenue.

Key Market Players

• Dragerwerk AG & Co. KGaA
• Masimo Corporation
• Cadwell Industries, Inc.
• NuroWave Systems, Inc.
• Neurosoft SA
• CGX (A Cognionics Company)
• Natus Medical, Inc.
• Nihon Kohden Corporation
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.

Report Scope

In this report, the Global Brain Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Brain Monitoring Market, By Device

• EEG
• EMG
• MEG
• ICP
• MRI
• fMRI
• CT

Brain Monitoring Market, By End-User

• Hospitals
• Neurology Centers
• Clinics & ASC

Brain Monitoring Market, By Application

• Traumatic brain injury (TBI)
• Stroke
• Dementia
• Headache disorders
• Sleep disorders
• Parkinson disease
• Epilepsy
• Huntington disease
• Other diseases

Brain Monitoring Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Brain Monitoring Market.

Available Customizations:

Global Brain Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Brain Monitoring Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device (EEG, EMG, MEG, ICP, MRI, fMRI, CT)
  • 5.2.2. By End-User (Hospitals, Neurology Centers, Clinics & ASC)
  • 5.2.3. By Application (Traumatic brain injury (TBI), Stroke, Dementia, Headache disorders, Sleep disorders, Parkinson disease, Epilepsy, Huntington disease, Other diseases)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Brain Monitoring Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device
  • 6.2.2. By End-User
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Brain Monitoring Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device
      • 6.3.1.2.2. By End-User
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Brain Monitoring Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device
      • 6.3.2.2.2. By End-User
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Brain Monitoring Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device
      • 6.3.3.2.2. By End-User
      • 6.3.3.2.3. By Application

7. Europe Brain Monitoring Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device
  • 7.2.2. By End-User
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Brain Monitoring Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device
      • 7.3.1.2.2. By End-User
      • 7.3.1.2.3. By Application
  • 7.3.2. France Brain Monitoring Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device
      • 7.3.2.2.2. By End-User
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Brain Monitoring Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device
      • 7.3.3.2.2. By End-User
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Brain Monitoring Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device
      • 7.3.4.2.2. By End-User
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Brain Monitoring Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device
      • 7.3.5.2.2. By End-User
      • 7.3.5.2.3. By Application

8. Asia Pacific Brain Monitoring Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device
  • 8.2.2. By End-User
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Brain Monitoring Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device
      • 8.3.1.2.2. By End-User
      • 8.3.1.2.3. By Application
  • 8.3.2. India Brain Monitoring Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device
      • 8.3.2.2.2. By End-User
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Brain Monitoring Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device
      • 8.3.3.2.2. By End-User
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Brain Monitoring Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device
      • 8.3.4.2.2. By End-User
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Brain Monitoring Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device
      • 8.3.5.2.2. By End-User
      • 8.3.5.2.3. By Application

9. Middle East & Africa Brain Monitoring Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device
  • 9.2.2. By End-User
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Brain Monitoring Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device
      • 9.3.1.2.2. By End-User
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Brain Monitoring Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device
      • 9.3.2.2.2. By End-User
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Brain Monitoring Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device
      • 9.3.3.2.2. By End-User
      • 9.3.3.2.3. By Application

10. South America Brain Monitoring Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device
  • 10.2.2. By End-User
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Brain Monitoring Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device
      • 10.3.1.2.2. By End-User
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Brain Monitoring Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device
      • 10.3.2.2.2. By End-User
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Brain Monitoring Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device
      • 10.3.3.2.2. By End-User
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Brain Monitoring Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dragerwerk AG & Co. KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Masimo Corporation
• 15.3. Cadwell Industries, Inc.
• 15.4. NuroWave Systems, Inc.
• 15.5. Neurosoft SA
• 15.6. CGX (A Cognionics Company)
• 15.7. Natus Medical, Inc.
• 15.8. Nihon Kohden Corporation
• 15.9. Koninklijke Philips N.V.
• 15.10. GE HealthCare Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer